Notable Analyst Rating Changes 06/03: (BRCM) (HUN) (EWBC) Upgraded; (CLVS) (ZQK) (AGN) Downgraded

June 3, 2014 10:43 AM EDT

Broadcom (Nasdaq: BRCM) raises by two today:
  • CLSA from Outperform to Buy; and

  • Wedbush from Neutral to Outperform while moving its price target from $30 up to $43. Click Here for more color.
Goldman Sachs boosts Huntsman (NYSE: HUN) from Buy to Conviction Buy with a price target of $32. Click Here for more color.

Barclays raises East West Bancorp (Nasdaq: EWBC) from Equalweight to Overweight and moves its price target from $38 to $40.

Susquehanna moves WisdomTree Investments (Nasdaq: WETF) from Neutral to Positive.

For daily real-time Upgrades go to

Citi downgrades Clovis Oncology (Nasdaq: CLVS) from Buy to Neutral.

Stifel Nicolaus cuts Quiksilver (NYSE: ZQK) from Buy to Hold and removed its $9 price target.

Credit Suisse shops Allergen (NYSE: AGN) from Outperform to Neutral.

Susquehanna drops Oil States International (NYSE: OIS) from Positive to Neutral.

For daily real-time Downgrades go to

Jefferies assumes Applied Materials (Nasdaq: AMAT) at Buy and price target of $28. Click Here for more color.

Oppenheimer initiates SUPERVALU (NYSE: SVU) with an Outperform rating and a price target of $10.

MLV & Co. begins RAIT Financial Trust (NYSE: RAS) with a Buy rating and a price target of $10.

Aegis Capital starts Biocept (Nasdaq: BIOC) at Buy and price target of $16.

For daily real-time New Coverage go to

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Credit Suisse, Stifel, Citi, Jefferies & Co, Barclays, Susquehanna International Group of Companies, Notable Analyst Rating Changes